0003-0213 : Daklinza 30 mg Oral Tablet
| NDC: | 0003-0213 |
| Labeler: | E.r. Squibb & Sons, L.L.C. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Daklinza |
| Dosage Form: | Oral Tablet |
| Application #: | NDA206843 |
| Rev. Date: |
Appearance:
| Markings: | BMS;213 |
| Shapes: |
Pentagon (5 sides) |
| Colors: |
 Green |
| Size (mm): | 7 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 0003-0213-01: 28 TABLET IN 1 BOTTLE (0003‑0213‑01)
Active Ingredients:
- Daclatasvir Dihydrochloride
Dosage Strength:
- 30 mg
Inactive Ingredients:
- Anhydrous Lactose
- Cellulose, Microcrystalline
- Croscarmellose Sodium
- Silicon Dioxide
- Magnesium Stearate
- Hypromelloses
- Titanium Dioxide
- Polyethylene Glycol 400
- Fd&c Blue No. 2
- Indigotindisulfonate Sodium
- Aluminum Oxide
- Ferric Oxide Yellow
Pharmaceutical Classes:
- Hepatitis C Virus NS5A Inhibitor [EPC]
- P-Glycoprotein Inhibitors [MoA]
- Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
- Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
- Breast Cancer Resistance Protein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0003-0011 Daklinza 90 mg Oral Tablet by E.r. Squibb & Sons, L.L.C.
- 0003-0215 Daklinza 60 mg Oral Tablet by E.r. Squibb & Sons, L.L.C.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0003-0011Next: 0003-0215 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.